Fig. 1From: Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancerROC curve for the outcome of interval cytoreduction surgery by preoperative serum CA-125 level, decreasing kinetics, and ascites volumeBack to article page